News IBM Watson impresses in brain tumour analysis Watson for Genomics produces treatment insights for glioblastoma in 10 minutes.
News Head patch device Optune improves brain cancer survival Median overall survival improved from 15 months to 21 months when combined with chemotherapy.
Views & Analysis Digital Health Round-up - Is AI the future of cancer drug de... Does artificial intelligence hold the key to cancer drug R&D?
News BERG begins trial for AI-engineered brain cancer drug Drug will be tested as a monotherapy for glioblastoma multiforme.
News Electrical patch device shows promise against ovarian cancer Novocure's Optune device shown to be safe and tolerable in recurrent ovarian cancer.
News Quartet of biotechs join Nasdaq after stellar IPOs Braveheart Bio, Latigo Biotherapeutics, Attovia Therapeutics, and BlossomHill Therapeutics have finalised their Nasdaq listings, raising over $1.2bn.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
